12h
Zacks Investment Research on MSNMAIA Biotechnology, Inc. (MAIA) Upgraded to Buy: Here's What You Should KnowInvestors might want to bet on MAIA Biotechnology, Inc. (MAIA), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...
Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued ...
Sana Biotechnology, Inc.’s SANA share price has dipped by 11.16%, which has investors questioning if this is right time to ...
A new part of an ocean plant cell has been discovered that might revolutionize farming one day. The structure can take ...
Analysts anticipate PDS Biotechnology to report an earnings per share (EPS) of $-0.30. Anticipation surrounds PDS ...
The International Society for Pharmaceutical Engineering (ISPE) has announced its keynote speakers at the 2025 ISPE Biotechnology Conference, taking place Monday, 2 June, through Tuesday, 3 June, in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results